ResMed Inc.
RMD
$251.69
$3.111.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.02B | 4.93B | 4.81B | 4.69B | 4.58B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.02B | 4.93B | 4.81B | 4.69B | 4.58B |
| Cost of Revenue | 2.04B | 2.02B | 2.00B | 2.00B | 1.99B |
| Gross Profit | 2.98B | 2.91B | 2.80B | 2.69B | 2.59B |
| SG&A Expenses | 968.08M | 952.70M | 933.24M | 917.14M | 915.63M |
| Depreciation & Amortization | 75.34M | 76.02M | 77.17M | 79.49M | 80.95M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.41B | 3.37B | 3.33B | 3.30B | 3.30B |
| Operating Income | 1.61B | 1.56B | 1.48B | 1.38B | 1.29B |
| Income Before Tax | 1.58B | 1.53B | 1.38B | 1.26B | 1.18B |
| Income Tax Expenses | 263.99M | 286.27M | 263.22M | 243.85M | 225.49M |
| Earnings from Continuing Operations | 1.31K | 1.25K | 1.11K | 1.02K | 958.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.31B | 1.25B | 1.11B | 1.02B | 958.38M |
| EBIT | 1.61B | 1.56B | 1.48B | 1.38B | 1.29B |
| EBITDA | 1.76B | 1.71B | 1.63B | 1.53B | 1.44B |
| EPS Basic | 8.94 | 8.50 | 7.57 | 6.94 | 6.52 |
| Normalized Basic EPS | 6.81 | 6.55 | 6.14 | 5.67 | 5.22 |
| EPS Diluted | 8.91 | 8.47 | 7.55 | 6.93 | 6.51 |
| Normalized Diluted EPS | 6.78 | 6.52 | 6.12 | 5.65 | 5.21 |
| Average Basic Shares Outstanding | 587.31M | 587.55M | 587.87M | 588.08M | 588.18M |
| Average Diluted Shares Outstanding | 589.83M | 590.06M | 590.13M | 590.01M | 590.04M |
| Dividend Per Share | 2.07 | 2.02 | 1.97 | 1.92 | 1.88 |
| Payout Ratio | 23.14% | 23.76% | 26.02% | 27.65% | 28.85% |